Biotech industry, anti-GMO activists face off over new NAFTA trade deal

The U.S., Canada and Mexico collectively addressed agricultural biotechnology like genetically modified organisms for the first time in the new NAFTA deal, agreeing to language that experts see as a major step in America’s effort to export its biotech model across the globe.

The inclusion of the chapter is designed to set a standard for future trade deals and send a message to other U.S. trading partners, like the European Union and China, which U.S. seed and pesticide manufacturers have criticized for having an unpredictable regulatory approach, said Andy LaVigne, president and CEO of the American Seed Trade Association.

…

Groups representing biotech companies and agribusiness contend the provisions in the U.S.-Mexico-Canada Agreement, or USMCA, are aimed at making trade in GE products more predictable and ensuring that disputes can be resolved more quickly, while also protecting billions of dollars in biotech industry investments in research and development.

Critics argue the language — if adopted in future trade agreements — would make it more difficult for countries to regulate GE crops and block shipments of varieties that haven’t been approved. More broadly, they say it could further entrench corporate control of new seed varieties and pesticides and limit farmers’ options in the marketplace.

Read full, original article: New NAFTA furthers U.S. push to set global rules on ag biotech (Behind Paywall)

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Personalized-Cancer-mRNA-Vaccine-Vial
Personalized mRNA vaccines are poised to revolutionize cancer treatments. Here are the barriers.
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-10-11-at-10.24.21-AM
Viewpoint: RFK Jr.’s new CDC head Erica Schwartz greenlights hepatitis B vaccine study critics call “unethical and designed to cast doubts on its safety”
Screenshot-2026-09-22-at-12.26.15-PM
‘Forever chemical’ concerns: Separating hysteria from reasonable concern in the debate over PFAS danger
Screenshot-2026-10-05-at-11.57.44-AM
Scaremongering or legitimate safety concerns? The political dogfight over America’s food safety system
Deepfake Democracy Media Mosaic
31 states have passed a patchwork of laws to limit election deepfake commercials. They’re not working very well.
Screenshot 2026-10-12 at 12.25
Tearful onions? CRISPR has a solution for that
Screenshot-2026-10-08-at-1.23.28-PM
Countries around the world are rushing to pass teenage social media bans. Could they backfire?
AI-Force-Uniform-Insignia-Close-Up
Trump wants an AI Force like Space Force, but that could make AI’s risks harder to manage
Radioactive-Americana-Collage-2
The kooky logic behind the raft of spurious cancer claims from Harvard’s T.H. Chan School of Public Health
generated-1790707585414
Facts & Fallacies podcast: America's health care system is broken. A doctor explains how to fix it
Screenshot-2026-09-22-at-10.54.12-AM
‘They misunderstand science’: Research attempting to tie autism to changes in the gut microbiome comes under fire
AI Doctor with a Digital Neural Head
Utah becomes first state to empower AI to bypass doctors and prescribe certain drugs
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.